News
NWBO
0.282
+4.41%
0.012
Weekly Report: what happened at NWBO last week (1223-1227)?
Weekly Report · 12/30/2024 12:15
Northwest Biotherapeutics Announces $5 Mln Convertible Note, $50 Mln Standby Financing Deals
NASDAQ · 12/26/2024 16:01
Northwest Biotherapeutics announces $5M convertible note financing and standby facility for up to $50M additional financing
Seeking Alpha · 12/26/2024 14:37
NORTHWEST BIOTHERAPEUTICS ANNOUNCES $5 MILLION CONVERTIBLE NOTE FINANCING AND STANDBY FACILITY FOR UP TO $50 MILLION ADDITIONAL FINANCING
Reuters · 12/26/2024 14:30
Press Release: Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
Dow Jones · 12/26/2024 14:30
Weekly Report: what happened at NWBO last week (1216-1220)?
Weekly Report · 12/23/2024 12:24
Weekly Report: what happened at NWBO last week (1209-1213)?
Weekly Report · 12/16/2024 12:25
Northwest Biotherapeutics: All Is Not Well With This One
Seeking Alpha · 12/14/2024 08:43
Weekly Report: what happened at NWBO last week (1202-1206)?
Weekly Report · 12/09/2024 12:24
Weekly Report: what happened at NWBO last week (1125-1129)?
Weekly Report · 12/02/2024 12:24
Weekly Report: what happened at NWBO last week (1118-1122)?
Weekly Report · 11/25/2024 12:12
Weekly Report: what happened at NWBO last week (1111-1115)?
Weekly Report · 11/18/2024 12:08
Northwest Biotherapeutics, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/16/2024 05:40
Weekly Report: what happened at NWBO last week (1104-1108)?
Weekly Report · 11/11/2024 12:28
Weekly Report: what happened at NWBO last week (1028-1101)?
Weekly Report · 11/04/2024 12:23
Weekly Report: what happened at NWBO last week (1021-1025)?
Weekly Report · 10/28/2024 12:12
Weekly Report: what happened at NWBO last week (1014-1018)?
Weekly Report · 10/21/2024 12:06
Weekly Report: what happened at NWBO last week (1007-1011)?
Weekly Report · 10/14/2024 12:47
Weekly Report: what happened at NWBO last week (0930-1004)?
Weekly Report · 10/07/2024 12:32
Weekly Report: what happened at NWBO last week (0923-0927)?
Weekly Report · 09/30/2024 12:22
More
Webull provides a variety of real-time NWBO stock news. You can receive the latest news about Northwest Bio through multiple platforms. This information may help you make smarter investment decisions.
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.